µL of pTXB3 (100 ng µL -1 ). The thermocycling conditions were: 3 min of initial heating at 95°C
followed by 30 cycles of 95°C for 5 s, 60°C for 10 s, 72°C for 1 min and a final elongation step at 72°C
for 10 min. The PCR product was electrophoresed through a 1 % agarose gel. The product band was excised from the gel and purified with a QIAquick gel extraction kit (Qiagen 2) Preparation of pTXB3-NTF113M: pTXB3-NTF113M plasmid was prepared by the same cloning procedure as previously described 1 . The primers used to PCR-amplify DNA encoding 1-113 αHL residue are 5'-CGCGCGCCATGGCAGATTCTGATATTAATATTAAA-3' (forward) and 5'-ATTGATACAAAAGAGTATATGTGCGGAAGAGCCAAGGG-3' (reverse).
3) Preparation of pTXB3-NTF113F: pTXB3-NTF113F plasmid for NTF 113F expression was obtained by homologous recombination, which resulted in the removal of DNA encoding residues 114-126. pTXB3-NTF126 was digested by one of two enzymes (NcoI or SpeI) and each of the two linearized plasmids was used as a PCR template. Two sets of two primers were used to produce a plasmid containing a gene encoding residues 1-113F: 5'-CGATTGATACAAAAGAGTATTTCTGCATCACGGGAGATGCACTAGT-3' (forward, B_fwd) and 5'-CAGAAGTGGTCCTGCAACTTTAT-3' (reverse, A_rev) were mixed with the plasmid template linearized by NcoI and 5'-ATAAAGTTGCAGGACCACTTCTG-3' (forward, A_fwd) and 5'-GAAATACTCTTTTGTATCAATCGAAT-3' (reverse, B_rev) were mixed with the plasmid template linearized by SpeI ( Figure S2C ). The underlined sequences in the primers represent the codon for M113F. The thermocycling conditions were: 3 min of initial heating at 95°C followed by 30 cycles of 95°C for 5 s, 60°C for 10 s, 72°C for 4 min and a final elongation step at 72°C for 10 min. The size of the products was checked in a 1% (w/v) agarose gel. The two PCR fragments (10 µL each) were mixed together with E. coli XL-10 Gold Ultracompetent cells (100 µL, Agilent) and incubated on ice for 30 min.
The cells were plated onto ampicillin plates (100 µg mL -1 ), which were incubated overnight at 37°C. A colony was picked and grown overnight again in 10 mL LB medium containing the same concentration of ampicillin. Plasmid pTXB3-NTF113F was extracted with a QIAprep miniprep kit (Qiagen) and the sequence of the insert was verified by Sanger sequencing with sequencing primers provided from Source Bioscience (T7F and T7R).
Preparation of CTF plasmids pT7-SC1-CDH plasmid encoding CTF 127 was prepared by the same method as previously described tag ( Figure S5 ). The homologous recombination procedure carried out to produce pT7-CTF Δ114 -DH was the same as described in the preparation of pTXB3-NTF113F section except that different restriction enzymes and primers were used. 1) Removal of αHL codons 1-113 from pT7-TBMΔ6: NdeI and HindIII were used to digest pT7-TBMΔ6. ), which were incubated overnight at 37°C. In order to culture a starter, a colony was transferred into LB medium (5 mL) containing the same concentration of ampicillin and grown overnight. The starter was transferred into 100 mL of LB medium and the culture monitored at 37°C until the OD 600 reached ~0.6. IPTG was added (100 µM final concentration) to induce expression and the culture was continuously grown for 4 h under the same conditions. The cells were centrifuged at 4,000 g for 20 min at 4°C. To lyse the cells, 5 mL of BugBuster® (Merck Millipore) was added to the cell pellets and shaken at 20°C for 30 min. The lysates were centrifuged again at 4,000 g for 30 min at 4°C. 1 µL of the supernatants and pellets were examined by SDS/PAGE to verify the overexpressed NTFs were mainly in the cell pellet (inclusion bodies). The cell pellets were resuspended in a denaturing buffer (5 mL of 8 M urea, 50 mM NaH 2 PO 4 (pH 7.0), 250 mM NaCl, 5 mM TCEP). The concentration of urea in the resuspended cell pellets was diluted to 1 M by mixing with 35 mL of 50 mM NaH 2 PO 4 (pH 7.0), 250 mM NaCl, 5 mM TCEP for the chitin-binding domain (CBD) to refold and bind to the chitin column. The resuspended pellets were loaded onto a chitin column (bed volume: 5 mL) and washed with 100 mL of 1 M urea, 50 mM NaH 2 PO 4 (pH 7.0), 250 mM NaCl, 5 mM TCEP. NTF- Preparation and purification of CTFs pT7-SC1-CDH and pT7-CTF Δ114 -DH plasmids were separately transformed into E. coli BL21 (DE3, pLysS, Promega). The cells were plated onto ampicillin (100 µg mL -1 ) and incubated overnight at 37°C.
A colony was picked and inoculated in LB medium (5 mL) containing the same concentration of ampicillin. The medium was grown at 37°C overnight for the starter culture. The starter was again transferred to 100 mL of LB medium containing the same concentration of ampicillin. The culture was incubated at 37°C until the OD 600 reached ~0.6. IPTG was added (100 µM final concentration) to induce expression and the culture was further grown for 4 h. The cells were centrifuged at 4,000 g for 20 min at 4°C. To lyse the cells, 5 mL of BugBuster® (Merck Millipore) was added to the cell pellets and shaken at 20°C for 30 min. The lysates were centrifuged again at 4,000 g for 30 min at 4°C. CTFs were found in the cell pellet and a denaturing buffer (5 mL of 6 M Gu·HCl, 50 mM NaH 2 PO 4 (pH 7.5), 250 mM NaCl, 5 mM TCEP) was added to dissolve the CTFs in the inclusion bodies. For separation of CTFs, the resuspended cell pellets were filtered by a syringe filter (Millipore, 0.22 µm) to remove cell debris before purification.
Purification of CTFs containing the His 6 -tag was carried out with an automated chromatography system (ÄKTA purifier, GE Healthcare Life Sciences) at a flow rate of 0.5 mL min-1 by using a Ni-NTA column (HisTrap, 1mL). Prior to injection, the Ni-NTA column was washed with 10 column volumes (CV) of distilled water and subsequently equilibrated with 5 CV of eluant A (6 M Gu·HCl, 50 mM phosphate (pH 7.5), 250 mM NaCl, and 5 mM TCEP). The cell pellet dissolved in eluant A was directly injected onto the column and the column was washed with 5-10 CV of buffer A to elute unbound protein. The separation was performed by applying a gradient from 0 to 50 % of eluant B in eluant A (eluant B: 6 M Gu·HCl, 50 mM phosphate (pH 7.5), 250 mM NaCl, 5 mM TCEP, and 500 mM imidazole). The separation was monitored at 280 nm. The purified CTFs were used directly without any further step to remove imidazole.
Synthesis of Fmoc-N 6 -(3-oxobutanoyl)lysine (Fmoc-Ket-OH)
Fmoc-Lys-OH, dichloromethane (DCM), and glacial acetic acid were obtained from Novabiochem and N-hydroxysuccinimidyl acetoacetate (NHA) was from Sigma-Aldrich. 1.0 mmol NHA was dissolved in 20 mL DCM and added to a 50 mL DCM suspension containing 1.1 mmol Fmoc-Lys-OH and 1.1 mmol N,N-diisopropylethylamine (DIEA). The reaction mixture was stirred for 6 h. The reaction was monitored by silica gel thin layer chromatography (TLC) using 10 % (v/v) MeOH in DCM containing a drop of acetic acid. The crude product was purified by flash column chromatography (silica gel) using 7 % (v/v) MeOH in DCM. The product was washed with 5 % Na 2 CO 3 (3 × 50 mL) and water (2 × 50 mL) and subsequently dried over Na 2 (eluant A: 0.1% formic acid in water; eluant B: 0.1% formic acid in acetonitrile). The mass spectra were generated with MassLynx software (version 4.1, Waters) by combining mass spectra obtained over the major peak in the total ion chromatogram.
Preparation of CSP-Nbz

Analytical HPLC
The purified synthetic peptide (SP-Nbz) was further examined on an analytical reverse-phase column (Polaris C 18 5u, 100 mm × 4.6 mm) on an Agilent 1260 Infinity HPLC at a flow rate of 1 mL min -1 with a gradient from 5 to 95% of eluant B in eluant A, over 13 min (eluant A: 0.1% FA in water; eluant B: 0.1% FA in acetonitrile). The separation was monitored at 280 nm.
Purification of SM
The final ligation product (synthetic monomer, SM) was exchanged into denaturing purification buffer (8 M urea, 50 mM NaH 2 PO 4 (pH 7.0), 5 mM TCEP) by successive concentration, dilution and reconcentration with a centrifugal filter (MWCO, 3k). The concentrated material (< 100 µL) was injected onto a gel filtration column (Superdex™ 200 10/300 GL), which was equilibrated with the same buffer and eluted at 0.4 mL min -1 . The separation was monitored at 280 nm.
Folding of purified SM
The denaturing buffer (8 M urea, 50 mM NaH 2 PO 4 (pH 7.0), 5 mM TCEP) used for the purification of SM was exchanged for the folding buffer (10 mM Tris·HCl, pH 7.4, containing 1 mM EDTA) with a centrifugal filter (Amicon, MWCO 3k). SM in 8 M urea (500 μL) was centrifuged at 14,000 g for 20 min (4°C) to a volume of 100 μL. 400 µL of flow-through was discarded. The folding buffer (400 μL) was added to the filter and mixed with the concentrated SM by pipetting to dilute the urea 5-fold. The urea concentration was further reduced to ~60 mM by repeating the dilution and concentration.
Hemolysis assays 1) Preparation of rabbit red blood cells -Before hemolysis was performed, the rabbit red blood cells obtained from Envigo were washed with MBSA buffer (10 mM 3-[N-morpholino]propane sulphonic acid (MOPS), 150 mM NaCl, pH 7.4, containing 1% bovine serum albumin). 450 µL of rabbit red blood cells was transferred to a 1.5 mL microcentrifuge tube and mixed with 900 µL of MBSA buffer. The rabbit red blood cells were centrifuged at 1,000 rpm for 2 min. The supernatant was discarded and the pellet was diluted to 10 mL with MBSA buffer.
2) Hemolysis was performed on a transparent 96-well microplate. αHL monomers were serially two-fold diluted with MBSA such that each well contained a volume of 50 μL. For example, SM f (1 μL) was mixed with MBSA (99 μL) in the first well. Half of the first well (50 μL) was transferred to the next well containing MBSA (50 μL) and mixed. In this way, serial dilution was continued to the twelfth well.
Rabbit red blood cells (50 μL) prepared by a protocol described above were then added to each well, starting with the well that contained the most dilute protein (i.e. twelfth well). Lysis was recorded by monitoring the decrease in light scattered at 595 nm with a microplate reader (Bio-Rad).
Ionic current recordings and single-molecule chemistry
Ionic current measurements were performed with a planar bilayer apparatus at room temperature. Data By using three different NTFs and two different CTFs, we synthetized three different αHL monomers (SM f (A), SM Δ6-113M (B), and SM Δ6-113F (C)). We folded the synthetic monomers and oligomerized them to form heptameric pores. WT 6 SM f1 , (SM Δ6-113M ) 7 , and (SM Δ6-113F ) 7 were used as nanoreactors. The residues depicted in red in a), b), and c) are Cys-127, Met-113, and Phe-113, respectively. The images of the αHL pores were prepared using Modeller and then reconstituted in Pymol. Note that the WT 6 SM f1 pore is a bottom view, while (SM Δ6-113M ) 7 , and (SM Δ6-113F ) 7 are top views. The B_rev and B_fwd primers were used with A_fwd and A_rev to produce pTXB3-NTF113F by using exactly same method described in Figure S2B . containing the His 6 -tag at the C-terminus were eluted when the eluant contained 50-100 mM imidazole.
The fractions of the CTF peak were pooled and directly used for characterization and the pyruvate removal step. The separation was monitored at 280 nm. were examined by SDS/PAGE prior to purification. E) and F) The fractions collected at each of peaks (P1, P2, and P3) were loaded onto SDS-gels to examine the purity of the synthetic monomers. 
